Inicio / Gastroenterología / Abstracts de gastroenterología / More is not always better:…

More is not always better: triplet chemotherapy and advanced gastric cancer

0 / 5 (0 votos)
More is not always better: triplet chemotherapy and advanced gastric cancer

The Lancet Gastroenterology & Hepatology

Fecha de publicación: 14 May 2019

DOI: https://doi.org/10.1016/S2468-1253(19)30145-1

Autores: Nina Fokter-Dovnik, Elizabeth C Smyth

Background: Gastric and gastro-oesophageal cancers are some of the most commonly diagnosed cancers worldwide and are an important cause of cancer-related death. Advanced gastric cancer has a poor prognosis with available palliative chemotherapy; average overall survival does not exceed 12 months in non-Asian patients.

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.